Skip to main content

Methotrexate

NDC 63323-123 · Fresenius Kabi USA, LLC

Generic nameMETHOTREXATE SODIUM

Dosage formINJECTION, SOLUTION

RouteINTRA-ARTERIAL, INTRAMUSCULAR, INTRAVENOUS

Active ingredient(s)METHOTREXATE SODIUM

Strength25 mg/mL

Pharmacologic classFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]

Marketing categoryANDA

Packages

63323-123-10 — 1 VIAL in 1 CARTON (63323-123-10) / 10 mL in 1 VIAL

Billed under HCPCS

J9260 — Injection, methotrexate sodium, 50 mg Medicare Part B payment limit (ASP + 6%): $2.94

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

59651-182 — Methotrexate, 61703-124 — Methotrexate, 61703-161 — Methotrexate, 61703-350 — Methotrexate, 61703-408 — Methotrexate, 62135-772 — Methotrexate, 62332-711 — methotrexate, 62332-712 — methotrexate, 62332-730 — METHOTREXATE, 63323-122 — METHOTREXATE SODIUM, 64850-330 — Methotrexate Sodium, 67046-1524 — Methotrexate, 68071-3765 — Methotrexate, 68071-3991 — Methotrexate, 71335-0782 — Methotrexate, 71335-1118 — methotrexate, 71335-1772 — Methotrexate, 71335-2221 — Methotrexate, 72162-2174 — Methotrexate Sodium, 72162-2647 — METHOTREXATE, +34 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.